Hodgkin lymphoma (HL) is a cancer of the lymphatic system and accounts for 12% of all lymphoma cases in Malaysia. The estimated age-standardized mortality rate of HL in this country is 0.23 per 100,000, which is higher than that of Singapore and Thailand. The disease is curable in most patients (ie, the 5-year relative survival rate of patients diagnosed at stages I and II of the disease >90%), but survivors may develop late treatment-related adverse effects. This online CPD video presents the clinical features of HL, along with an overview of its staging and prognosis. It also provides general practitioners/family physicians with information on the early signs and symptoms of the disease, and highlights the importance of early referral and intervention to maximize patient outcomes.
Dato Dr Chiang Kian Meng
MBBS (Mal), MRCP (UK), FRCP (Lon), FRCPA (Haem) Aust
Sunway Medical Centre
• Q&A session
Who should participate:
Please watch the video before attempting the assessment questions.
Terms & Conditions:
■ Participants must obtain a minimum score of 4/5 (80%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points
To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.